Data base, cold chain augmentation and transportation mechanism being readied.
Digital platform for vaccine delivery and monitoring has been prepared and tested in consultation with all the stakeholders.
Priority groups for Covid-19 vaccination like Health Workers, Frontline workers and other vulnerable groups being identified.
DELHI, NOVEMBER 20: Prime Minister, Shri Narendra Modi, today reviewed the preparedness of Covid-19 vaccine delivery, distribution and administration. Prime Minister appreciated the efforts of innovators, scientists, academicians and pharma-companies in their efforts to develop vaccines and has directed that every effort should be made to facilitate the research, development and manufacturing of the vaccine.
Five vaccines are in advanced stages of development in India, out of which 4 are in Phase II/III and one is in Phase-I/II. Countries such as Bangladesh, Myanmar, Qatar, Bhutan, Switzerland, Bahrain, Austria and South Korea – have shown keen interest in partnering for vaccine development of Indian vaccines and use thereof.
In an effort to administer the vaccine at the first available opportunity, database of healthcare and frontline workers, augmentation of cold chains and procurement of syringes, needles, etc. are in advanced stages of preparation.
The vaccination supply chain is being enhanced and non-vaccine supplies are being escalated. Medical and nursing students and faculty will be involved in training and implementation of the vaccination programme. Every step is being steadily put in place to ensure that vaccines reach every location and person according to the prioritisation principles.
The Prime Minister has directed to work in collaboration with all reputed national and international institutions and regulators to ensure the rigour and highest global standards in Indian research and manufacturing.
National Expert Group on Vaccine Administration for Covid-19 (NEGVAC) in consultation with State Governments and all relevant stakeholders have accelerated the implementation of vaccination of priority groups in first phase.
The digital platform for vaccine administration and distribution is prepared and test runs underway in partnership with the State and District Level stakeholders.
The Prime Minister reviewed the aspects of emergency use authorisation and for manufacture and procurement of medicine. As the results of these Phase III trials from national and international vaccine arrive, our robust and independent regulators will speedily and rigorously examine these for according authorisation for use.
The Government has provided assistance of Rs 900 crore under Covid Suraksha Mission to support Research & Development of Covid-19 vaccination.
The Prime Minister directed that a time-bound plan be laid out for speedy regulatory clearances and timely procurement for early rollout of the vaccination drive.
The Prime Minister appreciated comprehensive efforts at vaccine development. He also emphasised that given the persisting pandemic scenario there is no place for any relaxation in preventive measures such as wearing masks, keeping distance and ensuring hygiene.
The meeting was attended by Principal Secretary to PM, Cabinet Secretary, Member (Health) NITI Aayog, Principal Scientific Advisor, Secretary Health, DG ICMR, officers of PMO, and Secretaries of related Departments of Government of India.